Your session is about to expire
← Back to Search
Maraviroc + Exercise for Stroke Recovery (CAMAROS Trial)
CAMAROS Trial Summary
This trial is testing whether a CCR5 antagonist coupled with exercise can improve upper and lower extremity recovery after a stroke.
CAMAROS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCAMAROS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2008 Phase 4 trial • 18 Patients • NCT00666705CAMAROS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have been diagnosed with HIV.My kidney function is reduced with a creatinine clearance rate below 60 mL/min.I can move my shoulder slightly and extend fingers without gravity.I have a serious condition like Parkinson's or severe injury that was present before a stroke.I am currently on specific antifungal or antibacterial medications.You have a history of liver disease or high liver enzyme levels.I had some disability before my stroke.I am currently taking Carbamazepine, Phenobarbital, or Phenytoin.I am 18 years old or older.I am receiving inpatient rehab for weakness on one side of my body.I have had seizures caused by a stroke.I have epilepsy.I had a stroke between 5 days and 6 weeks ago.For the Upper Extremity Group:
- You need to have a certain level of strength in your shoulder and finger muscles.
- Your Upper Extremity Fugl-Meyer Assessment score should be above a certain number.
For the Lower Extremity Group:
- You need a lot of help from two people.
- Your walking speed should be below a certain speed, and you should not show certain movements in your hips.This criterion means that you must meet at least one of the conditions listed.You have a serious illness that makes it unlikely for you to survive for at least 1 year, or that would make it hard for you to participate in exercise and practice skills.I am currently taking St. John's Wort.I have help for daily rehab exercises and transport.I can move my shoulder slightly without gravity or can visibly move two or more fingers, or I can visibly move my hip.You have had dementia in the past.I had a stroke affecting the front part of my brain.I can move my shoulder slightly without gravity or can visibly move two or more fingers. Or, I can visibly move my hip.I can visibly bend and straighten my hip.You don't have the resources or health to live outside of a facility.
- Group 1: Maraviroc (Celsentri)
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the Maraviroc's standing with the FDA?
"Maraviroc's safety is only supported by Phase 2 trial data, which means that while there is some evidence of its safety, there is none for its efficacy. Thus, we've given it a score of 2."
What other research studies have included Maraviroc as a treatment?
"Maraviroc was first studied in 2009 at IRCCS Ospedale Pediatrico Bambino Gesu. To date, 18399 trials have been completed while 5 studies are still recruiting patients. These clinical trials tend to be based in Vancouver, Canada."
How many test subjects are required for this experiment?
"This particular study has completed recruitment for patients. The trial was posted on May 1st, 2022 and updated two days later. However, there are presently 1085 clinical trials actively searching for patients with stroke and 5 trials for Maraviroc that still require participants."
Are participants still being signed up for this experiment?
"This study is not currently looking for more patients. It was originally posted on May 1st, 2022 and last updated on the second of the same month. There are 1085 other trials related to stroke that are still recruiting patients, as well as 5 studies centred around Maraviroc."
Is this a groundbreaking new study?
"At this moment in time, there are 5 ongoing clinical trials involving Maraviroc taking place in 27 cities and 12 countries. The first study was completed in 2009 by ViiV Healthcare. A total of 103 patients were used in the Phase 2 drug approval stage trial. In the 11 years since 2009, a grand total of 18399 additional trials have been conducted."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Most responsive sites:
- Sunnybrook Health Sciences Centre: < 48 hours
Average response time
- < 2 Days
Typically responds via
Share this study with friends
Copy Link
Messenger